Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persistence of HepB Antibodies and Challenge Dose in Children
NCT00335881Phase 4Completed
- Sponsor
- GSK
- Start
- Jun 2006
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by GSK. Primary endpoint: Anti-HBs antibody concentration. Started Jun 2006; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00335881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00335881.